Chemical Structure (Cytarabine 01)
Cytarabine Injection, Solution
Product Images NDC 61703-305
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Cytarabine (NDC 61703-305). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Cytarabine 01a
Hospira Logo (Cytarabine 02)
Principal Display Panel (5 mL Vial Label)
Not available. The text appears to be a mix of random characters, numbers, and letters that do not form a coherent description.*
Principal Display Panel (5 mL Vial Carton)
This is a description of a medication in the form of Cytarabine Injection provided in 55 mL vials with NDC codes. It is a cytotoxic agent meant for intravenous, intrathecal, and subcutaneous use only. The injection is provided in single-dose vials and requires a prescription. Each vial contains 20 mg/mi of Cytarabine with some inactive ingredients, including Sodium Chloride and Water of Injection. The solution needs to be discarded if unused. The usual dosage depends on the individual prescription, and the package insert provides complete prescribing information. The medication should be protected from light and stored in a carton at temperatures ranging from 20°C to 25°C (B8F to 77°F). It is sterile and distributed by Hospira, Inc, located in Lake Forest, L 60045 USA.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
